Expressed RNAi for lasting treatment or cure

Tacere Therapeutics develops drugs for human conditions using RNA interference (RNAi) and ddRNAi gene-silencing technology from Benitec Biopharma. This approach, called Expressed RNAi, promises lasting treatment or cure with a single dose.

Our most advanced drug program – TT-034 for Hepatitis C – has commenced Phase l/lla clinical trial, with the first human dosed in May 2014. Our pipeline also includes drugs to treat Age-Related Macular Degeneration

Tacere Therapeutics is a Benitec Biopharma company.

Our biological drugs target and silence unwanted genes, safely and with lasting effect.

TT-034, our drug to treat Hepatitis C
with a single dose, has entered human clinical trials. More


Tacere Therapeutics Inc, 3942 Trust Way, Hayward, CA 94545, USAP. +1 925 858 9299           E.

Copyright © Tacere Therapeutics Inc. All rights reserved.                   Home | Contact